Dabur Challenges FSSAI '100%' Claim Ban, ₹150 Cr Stock at Risk
- 1Dabur India has moved court against FSSAI's directive to immediately stop selling products bearing '100%' claims, alleging that inventory worth approximately ₹150 crore is now at risk.
- 2The company argues that FSSAI issued the ban without providing a show-cause notice or opportunity to respond, violating due process.
- 3Eleven major products are affected, including Dabur Honey, Virgin Coconut Oil, and Réal Activ Coconut Water, though Dabur claims some products cited don't even carry the disputed claim.
- 4FSSAI maintains the '100%' claim violates Food Safety and Standards (Advertising and Claims) Regulations, 2018, deeming it misleading to consumers.
- 5Dabur has begun transitioning product labels and promotional materials to comply, even as it contests the regulatory order in court.
FMCG major alleges procedural lapses as regulatory order impacts 11 major products including Dabur Honey.
Dabur India's legal challenge against the Food Safety and Standards Authority of India (FSSAI) over restrictions on '100%' product claims has exposed critical tensions between regulatory enforcement and commercial realities in India's FMCG sector. With approximately ₹150 crore worth of inventory now in limbo, the case represents more than a compliance dispute—it's a watershed moment that could reshape how brands communicate product purity and authenticity across multiple categories.
The Regulatory Crackdown and Its Commercial Impact
FSSAI's directive to immediately halt sales of products featuring '100%' claims has created immediate operational challenges for Dabur. According to documents cited by Moneycontrol, the order affects 11 major SKUs spanning diverse categories—from Dabur Honey and Virgin Coconut Oil to Réal Activ Coconut Water. The breadth of impact underscores how deeply the '100%' claim had been integrated into Dabur's product positioning strategy. For a company of Dabur's scale, ₹150 crore in at-risk inventory translates to significant working capital implications, potential write-offs, and complex recall or relabeling operations across its distribution network. The immediate-effect nature of the ban, demanding compliance within 15 days alongside an action-taken report, has compressed decision-making timelines for the company's legal, regulatory, and marketing teams.
Procedural Fairness Questions
Dabur's central legal argument revolves around alleged procedural lapses in FSSAI's enforcement approach. The company contends that no show-cause notice was issued prior to the directive, denying it the opportunity to explain its labeling rationale or offer corrective measures voluntarily. This procedural grievance carries weight in Indian administrative law, where principles of natural justice typically require authorities to provide hearing opportunities before punitive action. More tellingly, Dabur claims that some products cited in FSSAI's order—including DABUR HOMMADE Coconut Milk and DABUR Cold Pressed Sesame Oil—don't actually display the disputed '100%' claim on their packaging. If accurate, this allegation suggests inadequate due diligence in the regulatory review process, raising questions about whether the action was, as Dabur characterizes it, implemented in a "mechanical manner" without thorough label assessment.
The Semantic Battle Over Comparative Claims
At the heart of this dispute lies a fundamental disagreement about what '100%' actually communicates to consumers. FSSAI's position, grounded in the Food Safety and Standards (Advertising and Claims) Regulations, 2018, treats such claims as inherently misleading. The regulator's framework aims to prevent unsubstantiated superiority claims that could confuse consumers or create unfair competitive advantages. Dabur's counter-argument asserts that phrases like '100% pure' are descriptive product attributes rather than comparative marketing statements. The company maintains these claims don't explicitly or implicitly undermine competing brands, but rather communicate product composition or processing methods. This distinction matters significantly—if '100%' is merely descriptive, it falls into a different regulatory category than claims suggesting competitive superiority. Dabur further notes that such terminology has become industry-standard language across FMCG categories, from honey and oils to juices and water, suggesting the regulatory interpretation represents a departure from established market practice.
Compliance in Motion Despite Legal Challenge
Despite its legal challenge, Dabur has initiated parallel compliance measures—a pragmatic approach that protects the company's market position while preserving its right to contest the regulatory interpretation. The company reports it has already begun modifying product labels, revising advertising creative, and updating online product references to eliminate the disputed claim. This dual-track strategy—fight the order legally while implementing changes operationally—reflects sophisticated regulatory risk management. It allows Dabur to maintain retail relationships, avoid potential penalties for non-compliance, and demonstrate good faith to both regulators and the judiciary. However, the financial and operational costs of this transition are substantial: new packaging design and approval, printing plate modifications, inventory obsolescence management, retailer communication, and consumer education about revised packaging.
This case illuminates the increasingly complex regulatory environment facing Indian FMCG brands as consumer protection frameworks mature and enforcement becomes more aggressive. The '100%' claim dispute is symptomatic of broader regulatory evolution—authorities are moving beyond basic safety compliance toward more nuanced scrutiny of marketing language, implicit promises, and consumer interpretation. For marketers, this signals the end of certain taken-for-granted claims language and demands more rigorous substantiation protocols for even seemingly innocuous product descriptors.
The timing is particularly significant given India's broader push toward consumer rights strengthening and the government's focus on preventing misleading advertising across sectors. FSSAI's hardline approach—immediate enforcement without graduated warnings—suggests regulators are prioritizing deterrence over collaborative compliance. This enforcement philosophy requires brands to invest more heavily in pre-market legal and regulatory review, rather than relying on post-market correction opportunities. The potential for inventory write-offs and sudden compliance demands creates new categories of business risk that must be factored into product development, launch planning, and working capital management.
The Dabur-FSSAI dispute serves as a clarion call for marketing and brand teams to audit product claims with renewed rigor. Seemingly innocuous descriptors like '100%,' 'natural,' 'pure,' or 'authentic' now warrant the same legal scrutiny as explicit health claims. Forward-looking brands should establish cross-functional claim governance frameworks involving legal, regulatory, R&D, and marketing stakeholders before finalizing packaging or campaign creative. In an environment where regulatory interpretation can shift suddenly and enforcement can be immediate, the cost of proactive compliance review is trivial compared to the commercial disruption of challenged claims. Most critically, marketers must recognize that industry-standard practice offers no protection—what competitors do successfully today may be tomorrow's regulatory target.
This article is an editorial rewrite based on reporting originally published by Free Press Journal. The original article has been rewritten and contextualised for India's marketing community by The Wise Marketing Desk using AI-assisted editorial tools.
Read original article at Free Press JournalFound this useful? Share it with your network.
Get India's best marketing news, daily.
Join 5,000+ marketing professionals reading The Wise Marketing.